Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
34 studies found for:    appendiceal cancer
Show Display Options
Rank Status Study
1 Recruiting Gastrointestinal Microbiome Study of Appendiceal Cancer
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasm;   Cancer, Appendiceal
Interventions: Other: Bio-specimen collection;   Other: Questionnaire
2 Completed
Has Results
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Conditions: Carcinoma of the Appendix;   Colorectal Cancer
Interventions: Drug: thalidomide;   Procedure: surgery
3 Recruiting Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI
Conditions: Colorectal Cancer;   Appendix Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Oxaliplatin
4 Completed Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer
Conditions: Carcinoma of the Appendix;   Colorectal Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Drug: oxaliplatin
5 Recruiting Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Condition: Gastrointestinal Neoplasms
Intervention: Behavioral: Questionnaire
6 Recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Conditions: Appendix Cancer;   Colorectal Cancer
Interventions: Procedure: Cytoreductive Surgery;   Drug: HIPEC with Mitomycin-C;   Drug: EPIC with FUDR and Leucovorin
7 Recruiting Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Condition: Cancer
Intervention: Drug: systemic chemotherapy
8 Recruiting Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasms
Intervention: Drug: PrevPac (Prevacid, Amoxicillin, Clarithromycin)
9 Completed
Has Results
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
Condition: Gastrointestinal Neoplasm
Interventions: Procedure: Cytoreductive surgery;   Procedure: Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP)
10 Enrolling by invitation Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
Conditions: Peritoneal Carcinomatosis;   Colorectal Cancer;   Appendiceal Cancer;   Peritoneal Mesothelioma;   Pseudomyxoma Peritonei;   Gastric Cancer
Intervention: Procedure: HIPEC
11 Recruiting The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
Condition: Appendicitis
Interventions: Drug: Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin;   Procedure: Appendectomy
12 Recruiting Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery
Condition: Solid Organ Cancers
Interventions: Biological: GL-ONC1;   Biological: Eculizumab
13 Active, not recruiting Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condition: Advanced GI Cancer
Intervention: Drug: MK-3475
14 Recruiting Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Condition: Carcinoma
Interventions: Drug: Intraperitoneal Oxaliplatin;   Drug: Bevacizumab;   Drug: Capecitabine
15 Active, not recruiting Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Conditions: Carcinoma of the Appendix;   Primary Peritoneal Cavity Cancer
Interventions: Drug: mitomycin C;   Drug: oxaliplatin;   Procedure: therapeutic conventional surgery;   Other: quality-of-life assessment;   Drug: hyperthermic intraperitoneal chemotherapy
16 Recruiting Cobimetinib and Atezolizumab in Advanced Rare Tumors
Conditions: Malignant Neoplasms of Digestive Organs;   Melanoma and Other Malignant Neoplasms of Skin;   Appendiceal Adenocarcinoma;   Cutaneous Squamous Cell Carcinoma;   Small Bowel Adenocarcinoma
Interventions: Drug: Cobimetinib;   Drug: Atezolizumab
17 Unknown  Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Interventions: Procedure: Hyperthermic intraoperative Peritoneal Chemoperfusion;   Drug: Hyperthermic intraoperative Peritoneal Chemoperfusion
18 Not yet recruiting Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
Conditions: Cancer, Appendiceal;   ColoRectal Cancer
Interventions: Drug: Mitomycin c;   Drug: Melphalan
19 Active, not recruiting French National Registry of Rare Peritoneal Surface Malignancies
Conditions: Rare Peritoneal Surface Malignancies;   Pseudomyxoma Peritonei;   Peritoneal Mesothelioma;   Desmoplastic Small Round Cell Tumor;   Psammocarcinoma;   Primary Peritoneal Serous Carcinoma;   Diffuse Peritoneal Leiomyomatosis;   Appendiceal Mucinous Neoplasms
Intervention: Other: Non interventional
20 Unknown  Optimizing Influenza Vaccination in Surgical Oncology Patients
Condition: Influenza
Intervention: Biological: Influenza vaccine

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.